Chinook Therapeutics Inc Cvr (ADRO)
Operating Cash Flow Growth
-8.11%
TTM · Period ending:
ADRO Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-8.11%period ending
Latest reported-8.11%period ending
ADRO TTM Cash from Operations YoY % (699.43% → -8.11%)
Year-over-year change
High-resolution chart · PNG
ADRO operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -8.1133% | |
| -29.8586% | |
| -4.7114% | |
| 4.7281% | |
| 51.5757% | |
| 42.6926% | |
| 31.4588% | |
| 22.6175% | |
| -2.0825% | |
| 14.006% | |
| -1.239% | |
| -3.2297% | |
| -41.8811% | |
| -132.7821% | |
| -161.1465% | |
| -155.6011% | |
| -134.7199% | |
| -123.6902% | |
| 781.762% | |
| 699.432% |